May 13, 2015

TB Alliance Launches “Nix-TB” Clinical Trial to Test New XDR-TB Treatment

First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB
March 23, 2015

Australia Grants Support for TB Alliance to Advance New TB Drugs

New funding supports new tools critical for tackling TB in the Asia-Pacific region and around the world
March 23, 2015

CPTR Marks Fifth Anniversary, Launches New Website

CPTRinitiative.org reflects partnership, progress, and perspectives from global thought leaders
March 23, 2015

TB Alliance Announces Partnership with U.S. Fund for UNICEF to Increase Access to Impending New Child-Friendly TB Treatments

Collaboration seeks to pull more sick children out of the shadows and into treatment for tuberculosis
March 17, 2015

The Lancet: Results of Phase 2b Trial of Novel TB Regimen PaMZ Show Potential to Shorten, Improve TB Treatment

Phase 3 STAND Trial Launches to Advance PaMZ through Final Stage of Testing
February 17, 2015

TB Alliance Advances Next-generation TB Drug Candidate into Clinical Testing

TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years
January 28, 2015

Phase 2a Published Results Show the Potential of a New TB Regimen with Novel Drugs Bedaquiline and Pretomanid (PA-824)

Results of study testing BPaZ published in American Journal of Respiratory and Critical Care Medicine; Regimen now being tested in Phase 2b clinical trial